General Counsel and Executive Vice President, Legal Affairs
In it to bring leading-edge science to the world.
With more than 20 years of experience in the biotechnology industry, Jean holds deep expertise in legal and business leadership. She oversees all aspects of the legal, compliance, and intellectual property functions at Seagen and serves as Corporate Secretary, advising on strategic matters.
Previously, Jean was the Vice President of General Counsel at Halozyme Therapeutics and the Chief Legal Officer and Corporate Secretary at Durect Corporation. Earlier in her career, Jean was an attorney at Pillsbury, Madison & Sutro (now Pillsbury Winthrop) and Venture Law Group, where she advised early-stage companies on technology transfer, licensing, patents, and copyright and trademark litigation.
Jean holds a J.D. from Columbia University, where she was a Harlan Fiske Stone Scholar. She also earned an M.S. in Biology from Stanford University and a B.S. in Cellular and Molecular Biology with highest distinction from the University of Michigan. She serves as a member of the board of directors for Connect Biopharma Holdings Ltd.
You are leaving Seagen.com
You are now leaving the Seagen site. Seagen does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only. Do you want to continue to the external site and leave Seagen.com?